Showing results (241-250 of 912) with videos related to
Sort By:
Pageof 92
Annals of General Psychiatry|January 1, 2020
Socio-demographic and substance-related factors associated with mental distress among Wollo university students: institution-based cross-sectional studyYosef Zenebe, Mogesie NechoAnnals of General Psychiatry|October 16, 2020
Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationshipAlv A Dahl, Kjersti Støen Grotmol, Marianne Jensen Hjermstad, et al.Annals of General Psychiatry|October 7, 2020
Psychometric investigation of the French version of the Aberrant Salience Inventory (ASI): differentiating patients with psychosis, patients with other psychiatric diagnoses and non-clinical participantsPhilippe Golay, Julien Laloyaux, Mihaela Moga, et al.Annals of General Psychiatry|October 5, 2020
Efficacy of nicotine administration on obsessions and compulsions in OCD: a systematic reviewDaria Piacentino, Annalisa Maraone, Valentina Roselli, et al.Annals of General Psychiatry|June 22, 2022
Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptionsMichael Cronquist Christensen, Hongye Ren, Andrea FagioliniAnnals of General Psychiatry|June 21, 2017
Amisulpride withdrawal dyskinesia: a case reportYu-Chi Lo, Ying-Chieh PengAnnals of General Psychiatry|February 15, 2022
The impact of COVID-related perceived stress and social support on generalized anxiety and major depressive disorders: moderating effects of pre-pandemic mental disordersAnna Monistrol-Mula, Mireia Felez-Nobrega, Joan Domènech-Abella, et al.Annals of General Psychiatry|May 16, 2018
Prevalence of postpartum depression and interventions utilized for its managementReindolf Anokye, Enoch Acheampong, Amy Budu-Ainooson, et al.Annals of General Psychiatry|November 3, 2023
Borderline personality disorder and early psychosis: a narrative reviewArianna Biancalani, Lorenzo Pelizza, Marco MenchettiAnnals of General Psychiatry|September 2, 2023
Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studiesPedro Sánchez, Cecilio Álamo, Marcos Almendros, et al.Pageof 92